Hasil Pencarian - Rajshekhar Chakraborty
- Menampilkan 1 - 18 hasil dari 18
-
1
-
2
-
3
-
4
Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma oleh George Mellgard, Molly Gilligan, Edward R. Scheffer Cliff, Divaya Bhutani, Ghulam R. Mohyuddin, Andrew Eisenberger, Suzanne Lentzsch, Rajshekhar Chakraborty
Diterbitkan 2024-03-01
Artikel -
5
Impact of age on treatment utilization for newly diagnosed multiple myeloma: a nationwide retrospective cohort study oleh Ghulam Rehman Mohyuddin, Hira Mian, Anastasia Gayowsky, Hsien Seow, Rajshekhar Chakraborty, Gregory R. Pond, Samer Al Hadidi, Alissa Visram
Diterbitkan 2024-10-01
Artikel -
6
-
7
PB2151: CLINICAL FEATURES AND OUTCOMES OF DIFFUSE PULMONARY LIGHT CHAIN AMYLOIDOSIS: A RARE PRESENTATION OF SYSTEMIC AL AMYLOIDOSIS oleh Rajshekhar Chakraborty, Claudia Bellofiore, Marco Basset, Mario Nuvolone, Andrea Foli, Giampaolo Merlini, Giovanni Palladini, Mathew Maurer, Markus Mapara, Divaya Bhutani, Suzanne Lentzsch, Paolo Milani
Diterbitkan 2023-08-01
Artikel -
8
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study oleh Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina Schinke, Anita D’Souza, Meera Mohan
Diterbitkan 2024-03-01
Artikel -
9
Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development oleh Ahmad Iftikhar, Hamza Hassan, Nimra Iftikhar, Adeela Mushtaq, Atif Sohail, Nathaniel Rosko, Rajshekhar Chakraborty, Faryal Razzaq, Sonia Sandeep, Jason Neil Valent, Abraham Sebastian Kanate, Faiz Anwer
Diterbitkan 2019-05-01
Artikel -
10
Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020 oleh Oliver Van Oekelen, Nicole Birrer, William Wesson, Vincent L. Galate, Edward R. Scheffer Cliff, Aaron M. Goodman, Al-Ola Abdallah, Rajshekhar Chakraborty, Vinay Prasad, Ghulam Rehman Mohyuddin
Diterbitkan 2022-11-01
Artikel -
11
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy oleh Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory S. Calip, Mustafa S. Ascha, Xiaoliang Wang, Samuel M. Rubinstein, Sascha Tuchman, Luciano Costa, Benjamin Haaland, Smith Giri, Hira Mian, Rafael Fonseca, Douglas Sborov
Diterbitkan 2022-12-01
Artikel -
12
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review oleh Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira Mian, Luciano J. Costa, Douglas Sborov, Ghulam Rehman Mohyuddin
Diterbitkan 2024-01-01
Artikel -
13
Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study oleh Arleigh McCurdy, Hsien Seow, Gregory P. Pond, Anastasia Gayowsky, Rajshekhar Chakraborty, Alissa Visram, Rayan Kaedbey, Anita D’Souza, Ghulam Rehman Mohyuddin, Tanya M. Wildes, Rafael Fonseca, Hira Mian
Diterbitkan 2023-07-01
Artikel -
14
Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autolo... oleh Rajshekhar Chakraborty, Eli Muchtar, Shaji K. Kumar, Dragan Jevremovic, Francis K. Buadi, David Dingli, Angela Dispenzieri, Suzanne R. Hayman, William J. Hogan, Prashant Kapoor, Martha Q. Lacy, Nelson Leung, Morie A. Gertz
Diterbitkan 2017-08-01
Artikel -
15
Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma oleh Rajshekhar Chakraborty, Heloise Cheruvalath, Anannya Patwari, Aniko Szabo, Carolina Schinke, Binod Dhakal, Suzanne Lentzsch, Anita D’Souza, Ghulam Rehman Mohyuddin, Kelley Julian, Shonali Midha, Patrick Costello, Martin Kaiser, Melissa Ng Liet Hing, Simon J. Harrison, Edward R. Scheffer Cliff, Meera Mohan
Diterbitkan 2024-08-01
Artikel -
16
Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type oleh Eli Muchtar, Angela Dispenzieri, Shaji K. Kumar, David Dingli, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Prashant Kapoor, Nelson Leung, Rajshekhar Chakraborty, Stephen Russell, John A. Lust, Yi Lin, Ronald S. Go, Steven Zeldenrust, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz
Diterbitkan 2016-09-01
Artikel -
17
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study oleh Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al-Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits van Rhee, Anita D’Souza, Aniko Szabo, Carolina Schinke, Rajshekhar Chakraborty
Diterbitkan 2024-03-01
Artikel -
18
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma oleh Lindsay Hammons, Aniko Szabo, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Binod Dhakal, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Ravi Narra, Divaya Bhutani, Sharmilan Thanendrarajan, Siegfried Janz, Maurizio Zangari, Suzanne Lentzsch, Frits van Rhee, Juan Carlos Rico Crescencio, Anita D’Souza, Rajshekhar Chakraborty, Meera Mohan, Carolina Schinke
Diterbitkan 2023-08-01
Artikel